PROCEPT BioRobotics Corporation's latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Quarterly earnings show how the company performed and whether revenue and profits are growing or shrinking.
Earnings announcements tell investors how much money the company made and spent during the quarter.
Board elections show who will lead the company's decisions; Dr. Moll received 36.5 million votes in his favor.
Quarterly earnings show investor progress on revenue and costs before board elections and annual meetings.
Earnings reports help investors understand if the company is making progress toward profitability.
New directors bring experience; Puckett was CFO at Shockwave Medical and joins the Audit Committee.
Insider trading policies prevent leaders from unfairly buying or selling company stock based on secret information.
Stocky reads PROCEPT BioRobotics Corporation's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
PROCEPT BioRobotics Corporation's most recent tracked filing was a 10-Q on 5 Aug 2026: PROCEPT reports Q2 2026 financial results ending June 30.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.